Pharma Biz Nabs $120M For Liver Disease Drug Development
Mirum Pharmaceuticals on Wednesday said it has secured $120 million in financing during its Series A funding round, which will be used to finance the development of its drug candidate for...To view the full article, register now.
Already a subscriber? Click here to view full article